Anya Biopharm Inc. (TPEX:7776)
Taiwan · Delayed Price · Currency is TWD 33.05
+0.05 (0.15%)
At close: Sep 24, 2026
Anya Biopharm Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | -49.13 | -64.02 | -36.96 | -28.08 | -41.83 |
Depreciation & Amortization | 1.89 | 1.93 | 1.84 | 1.26 | 0.86 |
Stock-Based Compensation | - | - | 11.12 | - | - |
Other Operating Activities | -12.01 | 7.63 | -3.96 | -0.02 | 0.01 |
Change in Accounts Receivable | -0 | -11.72 | 0.01 | 0.39 | -0.17 |
Change in Accounts Payable | -5.45 | 0.91 | 4.77 | 0.7 | -0.25 |
Change in Other Net Operating Assets | -11.38 | -4.66 | -0.62 | 1.62 | -2.22 |
Operating Cash Flow | -75.57 | -69.93 | -23.81 | -24.13 | -43.6 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Capital Expenditures | -0.84 | -0.87 | -6.36 | -0.07 | -0.56 |
Sale (Purchase) of Intangibles | -0.08 | -0.12 | -0.19 | -3.4 | -0.14 |
Investment in Securities | 0.15 | -64.65 | -162.09 | - | -0.49 |
Other Investing Activities | -5.49 | -4.05 | -1.73 | -0.89 | -1.11 |
Investing Cash Flow | -6.26 | -69.69 | -170.36 | -4.36 | -2.29 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Long-Term Debt Repaid | - | -0.16 | -0.98 | -0.84 | -0.72 |
Lease Payments | -0.13 | -0.16 | -0.98 | -0.84 | -0.72 |
Net Debt Issued (Repaid) | -0.13 | -0.16 | -0.98 | -0.84 | -0.72 |
Issuance of Common Stock | - | - | 472 | - | - |
Other Financing Activities | - | - | - | 38.72 | 46.96 |
Financing Cash Flow | -0.13 | -0.16 | 471.02 | 37.89 | 46.24 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Foreign Exchange Rate Adjustments | -0.12 | 0.31 | 1.92 | -0 | -0.01 |
Net Cash Flow | -82.07 | -139.47 | 278.77 | 9.39 | 0.34 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | -76.4 | -70.81 | -30.17 | -24.2 | -44.16 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -584.97% | -435.16% | -139.69% | -1043.60% | -1769.15% |
Free Cash Flow Per Share | -1.56 | -1.44 | -0.91 | -10.61 | -19.37 |
Levered Free Cash Flow | -73.25 | -53.47 | -18.26 | -17.42 | - |
Unlevered Free Cash Flow | -72.93 | -53.14 | -18.04 | -17.4 | - |
Free Cash Flow After Leases | -76.53 | -70.97 | -31.14 | -25.04 | -44.88 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash Interest Paid | 0.51 | 0.52 | 0.3 | 0.02 | 0.02 |
Cash Income Tax Paid | 2.64 | 2.53 | 2.41 | 0.03 | 0.04 |
Change in Working Capital | -16.83 | -15.47 | 4.15 | 2.71 | -2.64 |